Finance

Beta
Lists
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$3.12
+11.43%
(+0.32) 1D
$3.45
+10.58% (+0.33)
After hours
Closed: Jun 23, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GALT...
Open
$2.71
High
$3.70
Low
$2.71
Mkt. cap
205.47M
Avg. vol.
323.69K
Volume
0.00
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.41
Beta
0.47
Shares outstanding
65.86M
No. of employees
9
Open
$2.71
High
$3.70
Low
$2.71
Mkt. cap
205.47M
Avg. vol.
323.69K
Volume
0.00
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.41
Beta
0.47
Shares outstanding
65.86M
No. of employees
9
News stories
From sources across the web
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorBiotechnology
Websitegalectintherapeutics.com
Analyst Ratings
Based on 1 analyst giving stock ratings to GALT in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for GALT in the last 3 months.
Highest
Current $3.12
$11.00 (+252.56%)
Average
$11.00 (+252.56%)
Lowest
$11.00 (+252.56%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Matthew Keller
H.C. Wainwright
Buy
Reiterated
$11.00
+252.6%
06/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.26M
2.61M
1.93M
2.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.36M
1.59M
1.43M
1.85M
Operating expense
4.62M
4.20M
3.36M
4.08M
Total operating expenses
4.62M
4.20M
3.36M
4.08M
Operating income
-4.62M
-4.20M
-3.36M
-4.08M
Other non operating income
-1.10M
-2.20M
-221.00K
983.00K
EBT including unusual items
-7.52M
-8.18M
-5.50M
-5.05M
EBT excluding unusual items
-7.52M
-8.18M
-5.50M
-5.05M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.52M
-8.18M
-5.50M
-5.05M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
26.00K
39.00K
25.00K
36.00K
Interest expense
-1.83M
-1.82M
-1.94M
-1.99M
Net interest expenses
-1.80M
-1.78M
-1.91M
-1.95M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer